AL

Anandmay Laxminarayan Sharma

Active Director Director DIN 07455433
DIN 07455433 First appointment Mar 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Anandmay Laxminarayan Sharma

Data last updated:

Anandmay Laxminarayan Sharma is a Director at Swasth Siddhi Pharmaceuticals Private Limited (since 2016). The company operates in Chemicals.

DIN 07455433
Primary Designation Director
Industry Chemicals
First Appointment 08 Mar 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Mar 20162016Active

Board colleagues of Anandmay Laxminarayan Sharma

Directorship timeline

Open interactive timeline →
Swasth Siddhi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anandmay Laxminarayan Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anandmay Laxminarayan Sharma

Anandmay Laxminarayan Sharma currently holds 1 directorship: Swasth Siddhi Pharmaceuticals Private Limited (Director, since 08 Mar 2016).

Anandmay Laxminarayan Sharma was first appointed on 08 Mar 2016 as Director at Swasth Siddhi Pharmaceuticals Private Limited.

The current boards of Anandmay Laxminarayan Sharma's companies include Govind Raj (Swasth Siddhi Pharmaceuticals Private Limited), Lokesh Kumar Gupta (Swasth Siddhi Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available